United States Antispasmodic Agent Market Report 2016

December 2016 | 104 pages | ID: U8B375B7D82EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antispasmodic Agent

Revenue, means the sales value of Antispasmodic Agent

This report studies sales (consumption) of Antispasmodic Agent in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott Laboratories (US)
• Alimentary Health Limited (Ireland)
• Edusa Pharmaceuticals (US)
• Ironwood Pharmaceuticals, Inc. (US)
• Lexicon Pharmaceuticals (US)
• Pharmos Corporation (US)
• Salix Pharmaceuticals, Inc. (US)
• Sucampo Pharmaceuticals, Inc. (US)
• Tioga Pharmaceuticals, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Antispasmodic Agent in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Antispasmodic Agent Market Report 2016

1 ANTISPASMODIC AGENT OVERVIEW

1.1 Product Overview and Scope of Antispasmodic Agent
1.2 Classification of Antispasmodic Agent
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Antispasmodic Agent
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Antispasmodic Agent (2011-2021)
  1.4.1 United States Antispasmodic Agent Sales and Growth Rate (2011-2021)
  1.4.2 United States Antispasmodic Agent Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTISPASMODIC AGENT COMPETITION BY MANUFACTURERS

2.1 United States Antispasmodic Agent Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antispasmodic Agent Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antispasmodic Agent Average Price by Manufactures (2015 and 2016)
2.4 Antispasmodic Agent Market Competitive Situation and Trends
  2.4.1 Antispasmodic Agent Market Concentration Rate
  2.4.2 Antispasmodic Agent Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTISPASMODIC AGENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Antispasmodic Agent Sales and Market Share by Type (2011-2016)
3.2 United States Antispasmodic Agent Revenue and Market Share by Type (2011-2016)
3.3 United States Antispasmodic Agent Price by Type (2011-2016)
3.4 United States Antispasmodic Agent Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTISPASMODIC AGENT SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Antispasmodic Agent Sales and Market Share by Application (2011-2016)
4.2 United States Antispasmodic Agent Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTISPASMODIC AGENT MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott Laboratories (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Antispasmodic Agent Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Laboratories (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Alimentary Health Limited (Ireland)
  5.2.2 Antispasmodic Agent Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Alimentary Health Limited (Ireland) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Edusa Pharmaceuticals (US)
  5.3.2 Antispasmodic Agent Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Edusa Pharmaceuticals (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Ironwood Pharmaceuticals, Inc. (US)
  5.4.2 Antispasmodic Agent Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Ironwood Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Lexicon Pharmaceuticals (US)
  5.5.2 Antispasmodic Agent Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Lexicon Pharmaceuticals (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Pharmos Corporation (US)
  5.6.2 Antispasmodic Agent Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Pharmos Corporation (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Salix Pharmaceuticals, Inc. (US)
  5.7.2 Antispasmodic Agent Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Salix Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Sucampo Pharmaceuticals, Inc. (US)
  5.8.2 Antispasmodic Agent Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Sucampo Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Tioga Pharmaceuticals, Inc. (US)
  5.9.2 Antispasmodic Agent Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Tioga Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 ANTISPASMODIC AGENT MANUFACTURING COST ANALYSIS

6.1 Antispasmodic Agent Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Antispasmodic Agent

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Antispasmodic Agent Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Antispasmodic Agent Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTISPASMODIC AGENT MARKET FORECAST (2016-2021)

10.1 United States Antispasmodic Agent Sales, Revenue Forecast (2016-2021)
10.2 United States Antispasmodic Agent Sales Forecast by Type (2016-2021)
10.3 United States Antispasmodic Agent Sales Forecast by Application (2016-2021)
10.4 Antispasmodic Agent Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antispasmodic Agent
Table Classification of Antispasmodic Agent
Figure United States Sales Market Share of Antispasmodic Agent by Type in 2015
Table Application of Antispasmodic Agent
Figure United States Sales Market Share of Antispasmodic Agent by Application in 2015
Figure United States Antispasmodic Agent Sales and Growth Rate (2011-2021)
Figure United States Antispasmodic Agent Revenue and Growth Rate (2011-2021)
Table United States Antispasmodic Agent Sales of Key Manufacturers (2015 and 2016)
Table United States Antispasmodic Agent Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antispasmodic Agent Sales Share by Manufacturers
Figure 2016 Antispasmodic Agent Sales Share by Manufacturers
Table United States Antispasmodic Agent Revenue by Manufacturers (2015 and 2016)
Table United States Antispasmodic Agent Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antispasmodic Agent Revenue Share by Manufacturers
Table 2016 United States Antispasmodic Agent Revenue Share by Manufacturers
Table United States Market Antispasmodic Agent Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antispasmodic Agent Average Price of Key Manufacturers in 2015
Figure Antispasmodic Agent Market Share of Top 3 Manufacturers
Figure Antispasmodic Agent Market Share of Top 5 Manufacturers
Table United States Antispasmodic Agent Sales by Type (2011-2016)
Table United States Antispasmodic Agent Sales Share by Type (2011-2016)
Figure United States Antispasmodic Agent Sales Market Share by Type in 2015
Table United States Antispasmodic Agent Revenue and Market Share by Type (2011-2016)
Table United States Antispasmodic Agent Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antispasmodic Agent by Type (2011-2016)
Table United States Antispasmodic Agent Price by Type (2011-2016)
Figure United States Antispasmodic Agent Sales Growth Rate by Type (2011-2016)
Table United States Antispasmodic Agent Sales by Application (2011-2016)
Table United States Antispasmodic Agent Sales Market Share by Application (2011-2016)
Figure United States Antispasmodic Agent Sales Market Share by Application in 2015
Table United States Antispasmodic Agent Sales Growth Rate by Application (2011-2016)
Figure United States Antispasmodic Agent Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories (US) Basic Information List
Table Abbott Laboratories (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Alimentary Health Limited (Ireland) Basic Information List
Table Alimentary Health Limited (Ireland) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alimentary Health Limited (Ireland) Antispasmodic Agent Sales Market Share (2011-2016)
Table Edusa Pharmaceuticals (US) Basic Information List
Table Edusa Pharmaceuticals (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Edusa Pharmaceuticals (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Ironwood Pharmaceuticals, Inc. (US) Basic Information List
Table Ironwood Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ironwood Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Lexicon Pharmaceuticals (US) Basic Information List
Table Lexicon Pharmaceuticals (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lexicon Pharmaceuticals (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Pharmos Corporation (US) Basic Information List
Table Pharmos Corporation (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pharmos Corporation (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Salix Pharmaceuticals, Inc. (US) Basic Information List
Table Salix Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Salix Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Sucampo Pharmaceuticals, Inc. (US) Basic Information List
Table Sucampo Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sucampo Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Tioga Pharmaceuticals, Inc. (US) Basic Information List
Table Tioga Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tioga Pharmaceuticals, Inc. (US) Antispasmodic Agent Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antispasmodic Agent
Figure Manufacturing Process Analysis of Antispasmodic Agent
Figure Antispasmodic Agent Industrial Chain Analysis
Table Raw Materials Sources of Antispasmodic Agent Major Manufacturers in 2015
Table Major Buyers of Antispasmodic Agent
Table Distributors/Traders List
Figure United States Antispasmodic Agent Production and Growth Rate Forecast (2016-2021)
Figure United States Antispasmodic Agent Revenue and Growth Rate Forecast (2016-2021)
Table United States Antispasmodic Agent Production Forecast by Type (2016-2021)
Table United States Antispasmodic Agent Consumption Forecast by Application (2016-2021)